Jonathan Dry

Jonathan Dry

Company: Tempus

Job title: Vice President, Scientific Discovery


Trends for ERBB2 and Her2-Targeting Therapies in Real-World Multi-Modal Data 10:00 am

The Tempus platform supports assessment of tumor genetics, transcriptomics, imaging and clinical outcomes across our vast US clinical network Integration of multiple data modalities enables integration of Her2 status in the context of most other clinical biomarkers relevant to breast cancer Transcriptomics can provide a surrogate to expand the clinical utility of Her2 outside of…Read more

day: Day Two

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.